API Intermediates & Speciality Chemicals

Shree Ganesh Remedies Board approved unaudited standalone and consolidated financial results for Q2 and H1 FY27 ending September 30, 2026. Standalone Q2 revenue declined to ₹2,329.47 lakhs from ₹3,031